当前位置:首页 - 行情中心 - 特一药业(002728) - 财务分析 - 现金流量表

特一药业

(002728)

  

流通市值:48.33亿  总市值:49.48亿
流通股本:5.01亿   总股本:5.13亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金459,424,569.14205,543,757.02982,118,788.89763,287,771.48
  收到的税费返还--3,116,430.55-
  收到其他与经营活动有关的现金3,241,348.512,822,691.238,506,168.566,550,502.69
  经营活动现金流入小计462,665,917.65208,366,448.25993,741,388769,838,274.17
  购买商品、接受劳务支付的现金141,390,065.0665,400,700.02231,852,321.31183,726,560.5
  支付给职工以及为职工支付的现金64,092,153.5434,161,178.09114,578,720.7685,500,588.17
  支付的各项税费29,243,884.9720,125,433.2791,280,757.5358,972,603.08
  支付其他与经营活动有关的现金142,548,976.9477,003,958.3311,941,045.21250,445,074.91
  经营活动现金流出小计377,275,080.51196,691,269.68749,652,844.81578,644,826.66
  经营活动产生的现金流量净额85,390,837.1411,675,178.57244,088,543.19191,193,447.51
二、投资活动产生的现金流量:
  取得投资收益收到的现金2,062,457.521,398,476.22795,560.28748,710.96
  处置固定资产、无形资产和其他长期资产收回的现金净额800800200,800200,000
  收到的其他与投资活动有关的现金766,996,000299,998,000195,000,000185,000,000
  投资活动现金流入小计769,059,257.52301,397,276.22195,996,360.28185,948,710.96
  购建固定资产、无形资产和其他长期资产支付的现金31,265,590.0613,448,694.9479,547,293.7955,854,596.88
  支付其他与投资活动有关的现金729,996,000314,998,000405,000,000285,000,000
  投资活动现金流出小计761,261,590.06328,446,694.94484,547,293.79340,854,596.88
  投资活动产生的现金流量净额7,797,667.46-27,049,418.72-288,550,933.51-154,905,885.92
三、筹资活动产生的现金流量:
  吸收投资收到的现金--15,436,169.0513,725,358.86
  取得借款收到的现金410,000,00080,000,000618,950,602.65420,000,000
  收到其他与筹资活动有关的现金82,271,310-184,000,000154,000,000
  筹资活动现金流入小计492,271,31080,000,000818,386,771.7587,725,358.86
  偿还债务支付的现金250,000,00050,000,000889,000,000677,000,000
  分配股利、利润或偿付利息支付的现金78,252,885.18405,704.224,913,403.9927,692,820.3
  支付其他与筹资活动有关的现金--37,336,006.4737,336,006.47
  筹资活动现金流出小计328,252,885.1850,405,704.2951,249,410.46742,028,826.77
  筹资活动产生的现金流量净额164,018,424.8229,594,295.8-132,862,638.76-154,303,467.91
五、现金及现金等价物净增加额257,206,929.4214,220,055.65-177,325,029.08-118,015,906.32
  加:期初现金及现金等价物余额125,636,694.41125,636,694.41302,961,723.49302,961,723.49
  期末现金及现金等价物余额382,843,623.83139,856,750.06125,636,694.41184,945,817.17
补充资料:
  净利润31,108,115.76-81,671,615.4-
  资产减值准备-938,933.55--305,798.2-
  固定资产和投资性房地产折旧30,318,262.15-56,271,060.28-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧30,318,262.15-56,271,060.28-
  无形资产摊销7,042,588.06-13,549,376.71-
  处置固定资产、无形资产和其他长期资产的损失-802.85-68,451.01-
  固定资产报废损失--818,804.44-
  财务费用2,011,538.68-3,770,236.12-
  投资损失-2,062,457.52--795,560.28-
  递延所得税6,642,079.5--7,914,019.29-
  其中:递延所得税资产减少6,749,620.38--6,916,229.01-
    递延所得税负债增加-107,540.88--997,790.28-
  存货的减少-32,283,233.67-25,090,917.51-
  经营性应收项目的减少105,031,380.73-45,813,227.51-
  经营性应付项目的增加-63,340,060.82-25,885,218.28-
  其他1,862,360.67-165,013.7-
  现金的期末余额382,843,623.83-125,636,694.41-
  减:现金的期初余额125,636,694.41-302,961,723.49-
  现金及现金等价物的净增加额257,206,929.42--177,325,029.08-
公告日期2026-08-212026-04-282026-03-242025-10-24
审计意见(境内)标准无保留意见
TOP↑